Encompass Health (EHC) Set to Announce Quarterly Earnings on Monday

Encompass Health (NYSE:EHC) will release its earnings data after the market closes on Monday, October 28th. Analysts expect Encompass Health to post earnings of $0.94 per share for the quarter. Encompass Health has set its FY24 guidance at $3.97-$4.22 EPS.Persons that wish to register for the company’s earnings conference call can do so using this link.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Monday, August 5th. The company reported $1.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.01 by $0.10. Encompass Health had a return on equity of 17.83% and a net margin of 7.88%. The business had revenue of $1.30 billion for the quarter, compared to analysts’ expectations of $1.30 billion. During the same period last year, the firm earned $0.95 earnings per share. The company’s revenue for the quarter was up 9.6% compared to the same quarter last year. On average, analysts expect Encompass Health to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Encompass Health Trading Down 1.3 %

EHC opened at $93.46 on Friday. The company has a debt-to-equity ratio of 1.08, a current ratio of 1.35 and a quick ratio of 1.35. The stock has a market capitalization of $9.40 billion, a price-to-earnings ratio of 23.84, a PEG ratio of 1.45 and a beta of 0.88. The business has a fifty day moving average price of $93.58 and a 200 day moving average price of $88.26. Encompass Health has a 12 month low of $57.55 and a 12 month high of $98.74.

Encompass Health announced that its Board of Directors has authorized a stock buyback plan on Wednesday, July 24th that permits the company to repurchase $500.00 million in outstanding shares. This repurchase authorization permits the company to reacquire up to 5.4% of its shares through open market purchases. Shares repurchase plans are typically an indication that the company’s leadership believes its shares are undervalued.

Encompass Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.73%. The ex-dividend date is Thursday, January 2nd. Encompass Health’s dividend payout ratio is presently 17.35%.

Analysts Set New Price Targets

Several research analysts have commented on EHC shares. Leerink Partners started coverage on shares of Encompass Health in a report on Wednesday, July 10th. They set an “outperform” rating and a $100.00 price target for the company. Leerink Partnrs upgraded shares of Encompass Health to a “strong-buy” rating in a research note on Wednesday, July 10th. Barclays dropped their target price on Encompass Health from $113.00 to $109.00 and set an “overweight” rating on the stock in a report on Tuesday, August 6th. UBS Group lifted their price target on Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a report on Wednesday, September 25th. Finally, KeyCorp initiated coverage on Encompass Health in a report on Friday, October 11th. They issued an “overweight” rating and a $115.00 price objective on the stock. Eight investment analysts have rated the stock with a buy rating and three have given a strong buy rating to the stock. According to MarketBeat, Encompass Health currently has an average rating of “Buy” and an average price target of $104.67.

Insiders Place Their Bets

In other news, CFO Douglas E. Coltharp sold 12,260 shares of the business’s stock in a transaction dated Tuesday, August 13th. The stock was sold at an average price of $86.34, for a total value of $1,058,528.40. Following the completion of the sale, the chief financial officer now directly owns 136,227 shares of the company’s stock, valued at approximately $11,761,839.18. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 2.10% of the company’s stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.